Published in Women's Health Weekly, June 8th, 2000
Speaking at the UBS Warburg Dillon Read Global Specialty Pharmaceuticals Conference in New York City, Bruce L. Downey, Barr said that patient recruitment for the Phase III clinical studies could begin as early as Summer 2000.
Seasonale is an innovative patent-protected oral contraceptive product being developed through an agreement with the Medical College of Hampton Roads, Eastern Virginia Medical School (EVMS).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly